List view / Grid view
China National Medical Products Administration (NMPA)
Filter the results
According to a recent article, China has approved a number of home-grown vaccines, offering alternatives to global drugmakers' products.
Following positive clinical trials, the Tagrisso drug has been given marketing authorisation in China for treatment of NSCLC.